On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Meet the 4 VC-Backed Biotech Startups That Just Landed Space in Kendall Square September 5, 2017 What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets June 26, 2017 Sanofi's Rumored Buyout Target Flexion Shows Off Mid-Stage Osteoarthritis Data June 11, 2017
